Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nadler

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Surgical Infections|January 14, 2017
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal InfectionJohn E Mazuski, Jeffrey M Tessier, Addison K May, et al.
Pediatric Obesity|August 5, 2024
An open-label 16-week study of liraglutide in adolescents with obesity post-sleeve gastrectomyAnna Zenno, Ejike E Nwosu, Syeda Z Fatima, et al.
Journal of Translational Medicine|July 24, 2019
Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAsMatthew D Barberio, Lora J Kasselman, Martin P Playford, et al.
Obesity Facts|November 14, 2025
Early-Onset of Obesity Model: Impact of Early-Onset Obesity on Comorbidity Risk and Life ExpectancyUrs C H Wiedemann, Erica L T van den Akker, Thomas M Barber, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Gut microbiome shifts in adolescents after sleeve gastrectomy with increased oral-associated taxa and pro-inflammatory potentialCynthia O Akagbosu, Kathryn E McCauley, Sivaranjani Namasivayam, et al.
Gut Microbes|February 19, 2025
Gut microbiome shifts in adolescents after sleeve gastrectomy with increased oral-associated taxa and pro-inflammatory potentialCynthia O Akagbosu, Kathryn E McCauley, Sivaranjani Namasivayam, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Surgical Infections|January 14, 2017
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal InfectionJohn E Mazuski, Jeffrey M Tessier, Addison K May, et al.
Pediatric Obesity|August 5, 2024
An open-label 16-week study of liraglutide in adolescents with obesity post-sleeve gastrectomyAnna Zenno, Ejike E Nwosu, Syeda Z Fatima, et al.
Journal of Translational Medicine|July 24, 2019
Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAsMatthew D Barberio, Lora J Kasselman, Martin P Playford, et al.
Obesity Facts|November 14, 2025
Early-Onset of Obesity Model: Impact of Early-Onset Obesity on Comorbidity Risk and Life ExpectancyUrs C H Wiedemann, Erica L T van den Akker, Thomas M Barber, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Gut microbiome shifts in adolescents after sleeve gastrectomy with increased oral-associated taxa and pro-inflammatory potentialCynthia O Akagbosu, Kathryn E McCauley, Sivaranjani Namasivayam, et al.
Gut Microbes|February 19, 2025
Gut microbiome shifts in adolescents after sleeve gastrectomy with increased oral-associated taxa and pro-inflammatory potentialCynthia O Akagbosu, Kathryn E McCauley, Sivaranjani Namasivayam, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Pageof 17